Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of December. As of December 30th, there was short interest totalling 189,900 shares, a growth of 21.2% from the December 15th total of 156,700 shares. Based on an average daily trading volume, of 1,488,100 shares, the short-interest ratio is presently 0.1 days.
Q BioMed Price Performance
Shares of QBIO stock opened at $0.01 on Friday. Q BioMed has a 12-month low of $0.01 and a 12-month high of $0.49. The company has a market capitalization of $909,090.00, a PE ratio of -0.04 and a beta of 2.44. The firm has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.03.
Get
Q BioMed alerts:
Q BioMed (OTCMKTS:QBIO – Get Rating) last released its earnings results on Thursday, November 3rd. The company reported ($0.03) EPS for the quarter. The business had revenue of $0.03 million for the quarter.
Q BioMed Company Profile
(Get Rating)
Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Read More
- Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.
Q BioMed Inc.(場外交易代碼:QBIO-GET Rating)是12月份空頭股數顯著增長的接受者。截至12月30日,空頭股數共有189,900股,較12月15日的156,700股增長21.2%。以日均成交量1,488,100股計算,目前短息比為0.1天。
Q BioMed性價比
QBIO股票上週五開盤報0.01美元。Q BioMed的12個月低點為0.01美元,12個月高位為0.49美元。該公司市值為909,090.00美元,本益比為-0.04,貝塔係數為2.44。該公司的50日移動均線價格為0.01美元,200日移動均線價格為0.03美元。
到達
Q BioMed警報:
Q BioMed(OTCMKTS:QBIO-GET Rating)最近一次發佈財報是在11月3日週四。該公司公佈了該季度每股收益(0.03美元)。該業務本季度的收入為30萬美元。
Q BioMed公司簡介
(獲取評級)
Q BioMed Inc.是一家生物醫學加速和開發公司,專注於許可、收購和向生命科學和醫療保健公司提供資源。該公司提供氯化鍶SR89和美沙酮,這是一種治療轉移性骨癌疼痛的放射性藥物。
閱讀更多內容
- 免費獲取有關Q BioMed(QBIO)的StockNews.com研究報告
- 市場回顧周-1/16-1/20
- Old Dominion是否表明Trucking正在踩剎車?
- 諾德斯特龍對零售業降價的擔憂
- 埃克森美孚股票:在Buy Point附近
- 高股息率的必和必拓認為中國推動了23年的增長
接受Q BioMed Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Q BioMed和相關公司的最新新聞和分析師評級的每日簡要摘要。